Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 241-245

  Soto Miranda, Ernesto ^a   Carreón Torres, Elizabeth ^a   Lorenzo, Karina ^a   Bazán Salinas, Berenice ^a   García Sánchez, Cynthia ^a   Franco, Martha ^a   Posadas Romero, Carlos ^a   Fragoso, José Manuel ^a   López Olmos, Victoria ^a   Madero, Magdalena ^a   Rodriguez Pérez, José Manuel ^a   Vargas Alarcón, Gilberto ^a   Pérez Méndez, Oscar ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Chronic kidney disease; Coronary heart disease; High density lipoproteins subclasses; Reverse cholesterol transport; Urinary protein to creatinine ratio

Indexed keywords

ANAZOLENE SODIUM; CREATININE; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE URINE LEVEL; DENSITOMETRY; DISEASE ASSOCIATION; FEMALE; GENDER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; LIPID COMPOSITION; MALE; PARTICLE SIZE; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; ULTRACENTRIFUGATION; ADOLESCENT; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMPUTER PROGRAM; ISOLATION AND PURIFICATION; MIDDLE AGED; URINE;

ADOLESCENT; ADULT; CHOLESTEROL; CREATININE; HUMANS; LIPOPROTEINS, HDL; MIDDLE AGED; PARTICLE SIZE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; SOFTWARE; YOUNG ADULT;

EID: 84867588277     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.028     Document Type: Article

References (34)

1. Navab, M., Reddy, S.T., Van Lenten, B.J., Fogelman, A.M., HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8 (2011), 222–232.
2. Rye, K.A., Barter, P.J., Predictive value of different HDL particles for the protection against or risk of coronary heart disease. Biochim Biophys Acta 1821 (2012), 473–480.
3. Williams, P.T., Krauss, R.M., Nichols, A.V., Vranizan, K.M., Wood, P.D., Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 31 (1990), 1131–1139.
4. Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., James, R.W., Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 277 (2002), 4301–4308.
5. Kontush, A., Chantepie, S., Chapman, M.J., Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 23 (2003), 1881–1888.
6. Castro, G.R., Fielding, C.J., Early incorporation of cell-derived cholesterol into pre-beta-migrating high density lipoprotein. Biochemistry 12:27 (1988), 25–29.
7. Huesca-Gómez, C., Franco, M., Luc, G., et al. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 51 (2002), 443–450.
8. Lee, J.Y., Lanningham-Foster, L., Boudyguina, E.Y., et al. Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice. J Lipid Res 45 (2004), 716–728.
9. Carreón-Torres, E., Juárez-Meavepeña, M., Cardoso-Saldaña, G., et al. Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand white rabbit. Atherosclerosis 181 (2005), 233–240.
10. Carreón-Torres, E., Rendón-Sauer, K., Monter-Garrido, M., et al. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolism. Clin Chim Acta 401 (2009), 37–41.
11. Pérez-Méndez, O., Álvarez-Salcedo, P., Carreón Torres, E., et al. Palmitic acid reduces the fractional catabolic rates of HDL apo A-I in vivo: contribution of the surface negative charge. Clin Chim Acta 378 (2007), 53–58.
12. Pérez-Méndez, O., Bruckert, E., Franceschini, G., et al. Metabolism of apolipoproteins A-I and A-II in subjects carrying similar apo A-I mutations, apo A-IMilano and apo A-IParis. Atherosclerosis 148 (2000), 317–326.
13. Moestrup, S.K., Nielsen, L.B., The role of the kidney in lipid metabolism. Curr Opin Lipidol 16 (2005), 301–306.
14. Glass, C.K., Pittman, R.C., Keller, G.A., Steinberg, D., Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 258 (1983), 7161–7167.
15. Holzer, M., Birner-Gruenberger, R., Stojakovic, T., et al. Uremia alters HDL composition and function. J Am Soc Nephrol 22 (2011), 1631–1641.
16. Cho, K.H., Park, S.H., Park, J.E., et al. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin Biochem 41 (2008), 56–64.
17. Vaziri, N.D., Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290 (2006), F262–F272.
18. National Kidney Foundation, NKF K/DOQI guidelines: clinical practice guidelines and clinical practice recommendations. Available at http://www.kidney.org/professionals/Kdoqi/guideline_upHD_PD_VA/va_guide1.htm, 2006 (Accessed June 27, 2012).
19. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (2009), 604–612.
20. Burden, R., Tomson, C. Guideline Development Committee, Joint Specialty Committee on Renal Disease of the Royal College of Physicians of London and the Renal Association. Identification, management and referral of adults with chronic kidney disease: concise guidelines. Clin Med 5 (2005), 635–642.
21. Agatston, A.S., Janowitz, W.R., Hildner, F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990), 827–832.
22. DeLong, D.M., DeLong, E.R., Wood, P.D., Lippel, K., Rifkind, B.M., A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 256 (1986), 2372–2377.
23. Franco, M., Bautista, R., Pérez-Méndez, O., et al. Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol 294 (2008), F84–F92.
24. Blanche, P.J., Gong, E.L., Forte, T.M., Nichols, A.V., Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665 (1981), 408–419.
25. Toledo-Ibelles, P., García-Sánchez, C., Avila-Vazzini, N., et al. Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclases. J Lipid Res 51 (2010), 1610–1617.
26. Garvey, W.T., Kwon, S., Zheng, D., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52 (2003), 453–462.
27. Pérez-Méndez, O., Torres-Tamayo, M., Posadas-Romero, C., et al. Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus. Clin Chim Acta 376 (2007), 17–22.
28. Braschi, S., Neville, T.A., Maugeais, C., Ramsamy, T.A., Seymour, R., Sparks, D.L., Role of the kidney in regulating the metabolism of HDL in rabbits: evidence that iodination alters the catabolism of apolipoprotein A-I by the kidney. Biochemistry 39 (2000), 5441–5449.
29. Rye, K.A., Duong, M.N., Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins. J Lipid Res 41 (2000), 1640–1650.
30. Gu, F., Jones, M.K., Chen, J., et al. Structures of discoidal high density lipoproteins: a combined computational-experimental approach. J Biol Chem 285:7 (2010), 4652–4665.
31. García-Sánchez, C., Torres-Tamayo, M., Juárez-Meavepeña, M., et al. Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome. Clin Chim Acta 412 (2011), 292–298.
32. Juárez-Meavepeña, M., Carreón-Torres, E., López-Osorio, C., et al. The Srb1 + 1050T Allele Is Associated with metabolic syndrome in children but not with cholesteryl ester plasma concentrations of high-density lipoprotein subclasses. Metab Syndr Relat Disord 10 (2012), 110–116.
33. Juárez-Rojas, J., Medina-Urrutia, A., Posadas-Sánchez, R., et al. High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus. Lupus 17 (2008), 981–987.
34. Espinola-Zavaleta, N., Soto-López, M.E., Carreón-Torres, E., et al. Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis. Circ J 73 (2009), 760–766.